On the recordJune 25, 2018
My concern is that you get these companies that come in that buy up a drug manufacturer, add no value, invest in no research, but simply crank up the price for speculative purposes.
Source
congress.govSheldon Whitehouse: “My concern is that you get these companies that come in that buy up a drug manufacturer, add no value, invest in no…”
Editor's note · Context
Whitehouse expresses concern about companies exploiting drug prices.
Share
More from Sheldon Whitehouse
Oct 1, 2026
This is a hugely important milestone but there are two big pieces of work in front of us.
Oct 1, 2026
We need more clarity on that, and when we have more clarity on that they’ll be back-and-forth to try to resolve those issues.
Sep 23, 2026
Most of the dealbreaker humps we’re over, but now it’s refining the language, taking raw agreements into legislative texts and figuring out what schedule for voting succeeds.
Oct 1, 2026
And when we have more clarity on that they’ll be back-and-forth to try to resolve those issues.
Other voices in this conversation
